Wisconsin Alumni Research Foundation

Total investments

40

Average round size

5M

Portfolio companies

24

Rounds per year

0.40

Lead investments

3

Follow on index

0.40

Exits

5

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsEducationMedical DeviceMedicalLife SciencePharmaceuticalMarket Research

Summary

Wisconsin Alumni Research Foundation appeared to be the Corporate Investor, which was created in 1925. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Madison.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Wisconsin Alumni Research Foundation, startups are often financed by Venture Investors, Wisconsin Investment Partners, State of Wisconsin Investment Board. The meaningful sponsors for the fund in investment in the same round are State of Wisconsin Investment Board, Wisconsin Investment Partners, Venture Management. In the next rounds fund is usually obtained by Wisconsin Investment Partners, State of Wisconsin Investment Board, Venture Management.

The higher amount of exits for fund were in 2018. Speaking about the real fund results, this Corporate Investor is 8 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually. This Wisconsin Alumni Research Foundation works on 8 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Energy Storage. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline FluGen, NeuWave Medical, Mithridion The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.

Show more

Investments analytics

Analytics

Total investments
40
Lead investments
3
Exits
5
Rounds per year
0.40
Follow on index
0.40
Investments by industry
  • Health Care (24)
  • Biotechnology (21)
  • Medical Device (11)
  • Medical (5)
  • Pharmaceutical (5)
  • Show 37 more
Investments by region
  • United States (38)
  • United Kingdom (2)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
13M
Group Appearance index
0.80
Avg. company exit year
10
Avg. multiplicator
1.15

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Leo Cancer Care 11 Jun 2024 Health Care Late Stage Venture England, Surrey, United Kingdom
NeuWave Medical 08 Feb 2008 Health Care, Manufacturing, Medical Device Early Stage Venture 4M United States, Wisconsin, Madison
Thrive EdTech 10 Jul 2022 E-Learning, EdTech, Education, Personalization, Skill Assessment Seed 150K Bangladesh, Dhaka, Dhaka

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.